Medicine & AI to Improve Outcomes by Discovering Undiagnosed Patients- NHS Clinicians Presenting at HIMSS

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?

Go back

Discovering 4-6 Times More Undiagnosed & Miscoded Patients for Screening

1:15 - 4:15PM CT June 3rd, 2023, Prevention, Risk Reduction, and Hereditary Cancer Session, Chicago, IL, USA

Venue: McCormick Place, Chicago, IL, USA

The results of our collaboration with leading oncologists, titled “AI to characterize patients with lung or ovarian cancer and those with cachexia for discovery of undiagnosed, misdiagnosed, and miscoded patients at scale in a privacy-preserving manner” will be presented at the annual American Society of Clinical Oncology (ASCO) annual meeting.

Please let us know if you are available to meet by registering through the link below or emailing us at

Schedule A Meeting


Dr. Vibhor Gupta
Director & Founder
Pangaea Data